10 days ago
NUVL
AnalystsAnupam RamaAnupam Rama's Stock Forecasts
AnalystsAnupam Rama
Sectors:
Analyst Ranking
Top 24%
#1104 out of 4705 analysts
Average Return
+2.14%
Win Rate
44%72 out of 164
Risk vs Reward
Poor
Good
Anupam Rama's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Vera Therapeutics IncVERA | +683.63% | $6.23 | $48.82 | 2023-04-12 - 2024-04-11 | Strong Buy |
Vera Therapeutics IncVERA | +215.28% | $13.55 | $42.72 | 2023-11-30 - 2024-10-11 | Strong Buy |
Bridgebio Pharma IncBBIO | +207.57% | $9.51 | $29.25 | 2022-11-18 - 2023-11-17 | Strong Buy |
Oric Pharmaceuticals IncORIC | +188.93% | $4.97 | $14.36 | 2023-03-21 - 2024-03-20 | Strong Buy |
G1 Therapeutics IncGTHX | +129.24% | $17.99 | $41.24 | 2017-06-12 - 2018-06-12 | Strong Buy |
Anupam Rama Analyst Color
Get additional color on Anupam Rama's coverage of popular stocks
a month ago
TVTX
a month ago
SWTX
a month ago
VERA
2 months ago
VERA
3 months ago
ANAB
3 months ago
SLDB
3 months ago
NBIX
6 months ago
ANNX
7 months ago
SNDX
7 months ago
BBIO
7 months ago
RARE
a year ago
APLS
Anupam Rama's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nuvalent IncNUVL | 6 | Strong Buy | $125.00 | +20.67% | Maintains | 10 days ago |
Replimune Group IncREPL | 4 | Strong Buy | $17.00 | +48.08% | Maintains | 20 days ago |
Travere Therapeutics IncTVTX | 3 | Strong Buy | $23.00 | +40.16% | Maintains | a month ago |
Apellis Pharmaceuticals IncAPLS | 9 | Strong Buy | $57.00 | +110.02% | Maintains | a month ago |
Springworks Therapeutics IncSWTX | 4 | Strong Buy | $68.00 | +121.72% | Maintains | a month ago |
Vera Therapeutics IncVERA | 7 | Strong Buy | $72.00 | +68.54% | Maintains | a month ago |
Amicus Therapeutics IncFOLD | 5 | Strong Buy | $16.00 | +52.38% | Maintains | 2 months ago |
Olema Pharmaceuticals IncOLMA | 3 | Strong Buy | $31.00 | +164.05% | Maintains | 2 months ago |
Ideaya Biosciences IncIDYA | 6 | Strong Buy | $66.00 | +113.59% | Maintains | 2 months ago |
Cogent Biosciences IncCOGT | 3 | Strong Buy | $19.00 | +68.89% | Maintains | 2 months ago |
Bridgebio Pharma IncBBIO | 6 | Strong Buy | $43.00 | +66.02% | Maintains | 2 months ago |
Neurocrine Biosciences IncNBIX | 13 | Strong Buy | $181.00 | +56.72% | Maintains | 2 months ago |
Anaptysbio IncANAB | 7 | Strong Buy | $75.00 | +125.77% | Maintains | 2 months ago |
Syndax Pharmaceuticals IncSNDX | 7 | Strong Buy | $33.00 | +72.50% | Maintains | 2 months ago |
Sage Therapeutics IncSAGE | 7 | Hold | $10.00 | +51.75% | Maintains | 2 months ago |
Day One Biopharmaceuticals IncDAWN | 3 | Strong Buy | $36.00 | +159.37% | Maintains | 2 months ago |
Solid Biosciences IncSLDB | 4 | Strong Buy | $15.00 | +147.93% | Upgrades | 3 months ago |
Zai Lab LtdZLAB | 9 | Strong Buy | $38.00 | +50.02% | Maintains | 3 months ago |
Sarepta Therapeutics IncSRPT | 9 | Strong Buy | $175.00 | +40.55% | Maintains | 5 months ago |
Kiniksa Pharmaceuticals International PLCKNSA | 2 | Strong Buy | $30.00 | +12.95% | Maintains | 5 months ago |
Annexon IncANNX | 3 | Strong Buy | $13.00 | +76.15% | Maintains | 6 months ago |
Oric Pharmaceuticals IncORIC | 2 | Strong Buy | $18.00 | +92.93% | Maintains | 7 months ago |
Rapt Therapeutics IncRAPT | 6 | Hold | $13.00 | +614.29% | Maintains | 7 months ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Strong Buy | $92.00 | +66.97% | Maintains | 7 months ago |
Generation Bio CoGBIO | 2 | Hold | $9.00 | N/A | Maintains | a year ago |
Rallybio CorpRLYB | 2 | Strong Buy | $18.00 | N/A | Maintains | a year ago |
Kodiak Sciences IncKOD | 5 | Hold | $10.00 | N/A | Maintains | 2 years ago |
G1 Therapeutics IncGTHX | 7 | Hold | $10.00 | N/A | Upgrades | 2 years ago |
Elevation Oncology IncELEV | 2 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Cytomx Therapeutics IncCTMX | 2 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Mirati Therapeutics IncMRTX | 3 | Strong Buy | $94.00 | N/A | Maintains | 2 years ago |
Atara Biotherapeutics IncATRA | 7 | Hold | $250.00 | N/A | Downgrades | 2 years ago |
Passage Bio IncPASG | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cytokinetics IncCYTK | 1 | Strong Buy | $58.00 | N/A | Initiates Coverage On | 3 years ago |
Oyster Point Pharma IncOYST | 1 | Hold | $23.00 | N/A | Downgrades | 3 years ago |
Theravance Biopharma IncTBPH | 1 | Hold | $12.00 | N/A | Upgrades | 3 years ago |
Vir Biotechnology IncVIR | 5 | Hold | $37.00 | N/A | Upgrades | 3 years ago |
Protagonist Therapeutics IncPTGX | 2 | Strong Buy | $55.00 | N/A | Upgrades | 3 years ago |
Chemocentryx IncCCXI | 3 | Hold | $38.00 | N/A | Upgrades | 3 years ago |
Erasca IncERAS | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 3 years ago |
Infinity Pharmaceuticals IncINFI | 2 | Strong Buy | $6.00 | N/A | Upgrades | 3 years ago |
Cyteir Therapeutics IncCYTT | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Hold | $54.00 | N/A | Downgrades | 4 years ago |
Korro Bio IncKRRO | 3 | Strong Buy | $56.00 | N/A | Upgrades | 4 years ago |
Bioatla IncBCAB | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 4 years ago |
Dyne Therapeutics IncDYN | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 4 years ago |
Allovir IncALVR | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 4 years ago |
Iteos Therapeutics IncITOS | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | $50.00 | N/A | Downgrades | 4 years ago |
Alnylam Pharmaceuticals IncALNY | 2 | Hold | $137.00 | N/A | Downgrades | 4 years ago |
Y Mabs Therapeutics IncYMAB | 1 | Strong Buy | $39.00 | N/A | Initiates Coverage On | 5 years ago |
Dova Pharmaceuticals IncDOVA | 2 | Strong Sell | $20.00 | N/A | Downgrades | 6 years ago |
La Jolla Pharmaceutical CoLJPC | 4 | Hold | $9.00 | N/A | Upgrades | 6 years ago |
Myokardia IncMYOK | 2 | Strong Buy | $81.00 | N/A | Maintains | 6 years ago |
Alexion Pharmaceuticals IncALXN | 2 | Strong Buy | $188.00 | N/A | Maintains | 6 years ago |
Otonomy IncOTIC | 3 | Strong Sell | N/A | N/A | Downgrades | 7 years ago |
Clearside Biomedical IncCLSD | 2 | Strong Buy | $18.00 | N/A | Maintains | 7 years ago |
Inflarx NvIFRX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 7 years ago |
Ptc Therapeutics IncPTCT | 2 | Hold | N/A | N/A | Upgrades | 7 years ago |
Prometheus Biosciences IncRXDX | 1 | Strong Buy | $20.00 | N/A | Maintains | 7 years ago |
Ironwood Pharmaceuticals IncIRWD | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.